medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 2

<< Back Next >>

Med Crit 2015; 29 (2)

Procalcitonin/C reactive protein (PCT/CRP) index as a predictor of mortality in patients with septic shock

Pérez PM, Palacios CA, Sauceda A, Aguirre SJ, Franco GJ
Full text How to cite this article

Language: Spanish
References: 9
Page: 64-69
PDF size: 194.02 Kb.


Key words:

Septic shock, procalcitonin, C-reactive protein, mortality, SOFA, APACHE II.

ABSTRACT

Objectives: Set if the PCT/CRP index admission in the intensive therapy is a predictor of mortality in patients with septic shock.
Design: Prospective, observational study of nonintervention.
Material and methods: Patients were evaluated with septic shock admitted from February 2012 to March 2014 in the Department of Intensive Care Medical Center ABC. Determinations of PCT and CRP at admission and at 24 hours were performed. The prognostic and organ failure scales with PCT/CRP as a predictor of mortality rate were compared.
Results: We included 51 patients diagnosed with septic shock, 24 male and 27 female; the average age was 67 ± 15. They had APACHE II and SOFA by an average of 11 ± 4 and 22.4 ± 4.5 points respectively. The site of origin of septic shock was found more frequently abdominal. In terms of mortality, no significant difference appeared. The average length of stay in ICU was 5 days. To maintain hemodynamic stability was required most use of two vasopressor. The group of non survivors, lactate levels were 5.24 ± 4 (p = 0.007) and a rate of PCT/CRP of 5.31 ± 7.38 (p = 0.000 for basal and 0.001 for 24 hour) and found positive correlation exists this index to levels of sodium, chloride, bicarbonate, base deficit and levels of CRP and PCT.
Conclusions: An index of PCT/CRP values in the above was observed to be associated with mortality in patients with septic shock.


REFERENCES

  1. Morrell M, Micek S. The management of severe sepsis and septic shock. Infect Dis Clin N Am. 2009;23:485-501.

  2. Quenot J, Binquet C. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Critical Care. 2013;17:R65.

  3. Derek A, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-851.

  4. Lam SW, Bauer SR, Guzman JA. Septic shock: the initial moments and beyond. Cleve Clin J Med. 2013;80(3):175-184.

  5. Suberviola B, Castellanos-Ortega A. Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Med Intensiva. 2012;36(3):177-184.

  6. Christ-Crain M, Müller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly. 2005;135:451-460.

  7. Phua J, Koay E. Lactate, procalcitonin, and amino-terminal pro-b-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock. 2008;29(3):328-333.

  8. Schuetz P, Albrich W. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine. 2011;9:107.

  9. Póvoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med. 2002;28:235-243.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2015;29